Mushroom consumption lowers the risk of cancer by 45%
Higher mushroom consumption is associated with a 45% lower risk of cancer, according to a new Penn State study.
Improving cancer treatment and services during and beyond COVID-19
Greg Quinn, BD UK, explores how cancer treatment and services have been impacted by the pandemic and the potential role of medical technology in supporting the NHS during this complex time.
Brain cancer therapeutics: Overcoming the barriers
Sean E. Lawler PhD from Brigham and Women’s Hospital, Harvard Medical School, sheds light on overcoming the barriers when it comes to brain cancer therapeutics.
FLASH Radiotherapy: An (r)evolution in cancer treatment
Here, Kristoffer Petersson, MRC Investigator and Group Leader of FLASH Radiation, enlightens us to the benefits of this promising new radiotherapy technique.
Cancer treatment: Radiotherapy
Cancer Centre London’s Keisha Robinson spoke to Open Access Government about cancer treatment in the UK today, in particular, radiotherapy.
Subtle ovarian cancer symptoms that should not be missed
In recognition of Ovarian Cancer Awareness Month, Dr Nicky Keay, Chief Medical Officer at Forth and expert in endocrinology and women’s health problems, takes a look at some of the most common symptoms that too often get overlooked.
The impact of the COVID-19 pandemic on cancer treatment
Experts from the International Agency for Research on Cancer and the University of Molise chart the impact of the COVID-19 pandemic on cancer treatment.
European Commission presents Europe’s Beating Cancer Plan
The European Commission has announced its Europe's Beating Cancer Plan which sets out a new EU approach to cancer prevention, treatment and care.
AI technology can help tackle the cancer care backlog
Hugh Bettesworth, CEO, Mirada Medical, explores how AI autocontouring technology can help tackle the cancer care backlog as a result of the COVID-19 pandemic.
Black women face racial disparities in breast cancer screening
Black women face higher mortality rates and recurrence of breast cancer, according to researchers from University of Illinois Chicago.
New drug combination effective in acute myeloid leukemia (AML) treatment
Scientists have identified two drugs that are effective in acute myeloid leukemia (AML) treatment when combined.
Ovarian cancer cells adjust to their environment to boost tumour growth
A new study revealing how ovarian cancer cells adapt to their environment to aid tumour growth brings researchers closer to developing targeted treatments.
Head and neck cancer treatment
Michelle Vickers, CEO of the Head and Neck Cancer Foundation tells us what we need to know about head and neck cancer treatment, including comment on driving surgical-technological development.
Cancer challenges in Sub-Saharan Africa
Zisis Kozlakidis, International Agency for Research on Cancer and Chite Asirwa, International Cancer Institute, walk us through the cancer challenges in Sub-Saharan Africa today.
Tackling the burden of pancreatic cancer in Europe
Leading pancreatic cancer experts Professor Matthias Löhr and Professor Monique van Leerdam of United European Gastroenterology’s (UEG) Public Affairs Committee discuss the importance of early diagnosis and the latest developments in treatment for pancreatic cancer.
New drug offers promising treatment for pancreatic cancer patients
Scientists have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer.
Honeybee venom found to kill agressive breast cancer cells
Researchers from the University of Western Australia have found that the venom of honeybees can destroy aggressive breast cancer cells in a lab setting.
Hearing loss in childhood cancer survivors linked to neurocognitive deficits
Scientists at St. Jude Children's Research Hospital have discovered that hearing loss in childhood cancer survivors is associated with an increased risk for neurocognitive deficits.
Oncology: Imaging biomarkers and the Alberta Radiopharmaceutical Collaboration
Dr Frank Wuest, Professor at Department of Oncology - University of Alberta, sheds light on the imaging biomarkers and the Alberta Radiopharmaceutical Collaboration in this special oncology focus.
Cancer research analysis: A focus on innovation
Here, the International Agency for Research on Cancer and other experts provide an in-depth analysis of cancer, the second leading cause of death after cardiovascular diseases plus the role of technology and innovation in the field.
